Ghost Tree Capital’s Sio Gene Therapies SIOX Stock Holding History
Bought
Maintained
Sold
Other funds holding SIOX
IA
IPLA
Ghost Tree Capital's SIOX Position: Q4 2017 in Review
Ghost Tree Capital sold out of Sio Gene Therapies (SIOX) in Q4 2017, closing a stake of 12,500 shares — an estimated $688K sold.
Ghost Tree Capital first reported a position in SIOX in Q2 2015 and held it in 5 quarters. The position peaked at $7.38M in Q2 2016. 105 funds tracked by Wall St. Rank hold SIOX as of Q4 2017.
- Ghost Tree Capital reported no remaining Sio Gene Therapies position as of Q4 2017 after selling out during the quarter.
- Ghost Tree Capital sold 12,500 Sio Gene Therapies shares in Q4 2017, an estimated $688K.
- Ghost Tree Capital first reported a position in Sio Gene Therapies in Q2 2015 and held it in 5 quarters.
- Ghost Tree Capital's Sio Gene Therapies position peaked at $7.38M in Q2 2016.
- 105 funds tracked by Wall St. Rank held Sio Gene Therapies as of Q4 2017.
Based on Ghost Tree Capital's 13F filing for Q4 2017, filed 14 Feb 2018.